Female infertility due to abnormal autoimmunity: frequently overlooked and greatly underappreciated. Part I

References

• Hornstein MD. Antiphospholipid antibodies in patients undergoing IVF: the data do not support testing. Fertil. Steril.74, 635–636 (2000).
   PubMed Web of Science ®Google Scholar
• Hill GA, Scott RT Jr. Immunologic tests and IVF: “please enough already”. Fertil. Steril.74, 439–442 (2000).
   PubMed Web of Science ®Google Scholar
• ASRM Practice Committee Report. Antiphospholipid Antibodies Do Not Affect IVF Success. American Society for Reproductive Medicine, AL, USA (1999).
   Google Scholar
• ASRI Antiphospholipid Antibody Committee. A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice Committee Opinion. Fertil. Steril.74, 631–634 (2000).
   PubMed Web of Science ®Google Scholar
• Kamradt T, Avrion Mitchison N. Tolerance and autoimmunity. N. Engl. J. Med.344, 655–664 (2001).
   PubMed Web of Science ®Google Scholar
• Davidson A, Diamond B. Autoimmune diseases. N. Engl. J. Med.345, 340–350 (2001).
   PubMed Web of Science ®Google Scholar
• Townsend A, Bodmer. Antigenic recognition by Class I restricted T lymphocytes. Annu. Rev. Immunol.7, 601–624 (1989).
   PubMed Web of Science ®Google Scholar
• Ortonne JP. Recent developments in the understanding of the pathogenesis of psoriasis. Br. J. Dermatol.140(Suppl. 54), 1–7 (1999).
   PubMed Web of Science ®Google Scholar
• Kukreja A, MacLaren NK. Autoimmunity and diabetes. J. Clin. Endocrinol. Metab.84, 4371–4378 (1999).
   PubMed Web of Science ®Google Scholar
• Gregersen PK. Genetic analysis of rheumatic diseases. In: Textbook of Rheumatology (5th Edition, Volume 1). Kelly WN, Harris ED Jr, Ruddy S, Sledge CB (Eds). WB Saunders, PA, USA 209–227 (1997).
   Google Scholar
• Gleicher N, Weiner R, Vietzke M. The impact of abnormal autoimmune function on reproduction: maternal and fetal consequences. J. Autoimmun.27, 161–165 (2006).
   PubMed Web of Science ®Google Scholar
• Hayashi T, Fustman DL. Role of defective apoptosis in type 1 diabetes and other autoimmune diseases. Rec. Prog. Hormone Res.58, 131–153 (2003).
   PubMedGoogle Scholar
• Encinas JA, Kuchroo VK. Mapping and identification of autoimmunity genes. Curr. Opin. Immunol.12, 691–697 (2000).
   PubMed Web of Science ®Google Scholar
• Becker KG. Comparative genetics of Type 1 diabetes and autoimmune disease: common loci, common pathways? Diabetes48, 1353–1358 (1999).
   PubMed Web of Science ®Google Scholar
• Klein J, Sato A. The HLA system. N. Engl. J. Med.343, 782–786 (2000).
   PubMed Web of Science ®Google Scholar
• Rose NR. Mechanisms of autoimmunity. Sem. Liver Dis.22, 387–394 (2001).
   Web of Science ®Google Scholar
• Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Grave’s disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab.86, 930–934 (2001).
   PubMed Web of Science ®Google Scholar
• Yuki N. Pathogenesis of Guillaine–Barre and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Jpn J. Infect. Dis.52, 99–105 (1999).
   PubMed Web of Science ®Google Scholar
• Regner M, Lambert P. Autoimmunity through infection or immunization? Nat. Immun.2, 185–188 (2001).
   Google Scholar
• Fairweather D, Rose NR. Type 1 diabetes: virus infection or autoimmune disease? Nat. Immun.3, 338–340 (2002).
   Google Scholar
• Wucherpfennig KW. Structural basis for molecular mimicry. J. Autoimmun.16, 293–302 (2001).
   PubMed Web of Science ®Google Scholar
• Rose NR, Mackay IR. Molecular mimicry: a critical look at exemplary instances in human disease. Cell Molec. Life Sci.57, 542–551 (2000).
   PubMed Web of Science ®Google Scholar
• Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type-1: autoimmune disease after viral infection. Science279, 1344–1347 (1998).
   PubMed Web of Science ®Google Scholar
• Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic mAb rheumatic carditis recognizes heart valves and laminin. J. Clin. Invest.106, 217–224 (2000).
   PubMed Web of Science ®Google Scholar
• Guilherem L, Cunha-Neto E, Coelho V et al. Human heart infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation92, 415–420 (1995).
   PubMedGoogle Scholar
• Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type 1 interferon in vivo. Science272, 1947–1950 (1996).
   PubMed Web of Science ®Google Scholar
• Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnik N. Diabetes induced by coxsackievirus: initiation by bystander damage and not molecular mimicry. Nat. Med.4, 781–785 (1998).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Pratt D, Dudkiewicz A. What do we really know about autoantibody abnormalities and reproductive failure: a critical review. Autoimmunity16, 115–140 (1993).
   PubMed Web of Science ®Google Scholar
• El-Roeiy A, Gleicher N. Definition of normal autoantibody levels in an apparently healthy population. Obstet. Gynecol.72, 596–602 (1988).
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Autoimmune Disease. Coordinating Committee Report, 2002. The Institutes, MD, USA (2002).
   Google Scholar
• Da Silva JAP. Sex hormones, glucocorticoids and autoimmunity: facts and hypothesis. Ann. Rheum. Dis.54, 6–16 (1995).
   PubMed Web of Science ®Google Scholar
• Whitacre CC. Sex differences in autoimmune disease. Nat. Immunol.2, 777–780 (2001).
   PubMed Web of Science ®Google Scholar
• McCarthy M. The “gender gap” in autoimmune disease. Lancet356, 1088 (2000).
   PubMed Web of Science ®Google Scholar
• Ackerman LS. Sex hormones and the genesis of autoimmune disease. Arch. Dermatol.142, 371–376 (2006).
   PubMedGoogle Scholar
• Cutolo M. Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J. Rheumatol.31, 419–421 (2004).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Barad DH. Gender as a risk factor for autoimmune disease. J. Autoimmun.28, 1–6 (2007).
   PubMed Web of Science ®Google Scholar
• Van Vollenhofen RF. Dehyrdoepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin. Pharmacother.3, 23–31 (2003).
   Google Scholar
• Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum. Reprod.21, 2845–2849 (2006).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad D. Adrenal function in women with premature aging ovaries. Fertil. Steril.86(Suppl. 2), S401 (2006).
   Google Scholar
• Lockshin MD. Sex ratio and rheumatic disease. IMAJ3, 511–516 (2001).
   Google Scholar
• Starzl DE, Demetris AJ, Murase N, Ildstad S, Ricodi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet339, 1579–1582 (1992).
   PubMed Web of Science ®Google Scholar
• Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N. Engl. J. Med.346, 5–15 (2002).
   PubMed Web of Science ®Google Scholar
• Raulet DH. Does a low level of expression of HLA molecules engender autoimmunity? N. Engl. J. Med.340, 314–315 (1999).
   PubMed Web of Science ®Google Scholar
• Gleicher N. Graft-versus-host disease (GVHD) and graft rejection, a feature of pregnancy and preeclampsia: a unifying hypothesis and implications for diagnosis and treatment. (2007) (In Press).
   Google Scholar
• Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years post-partum. Proc. Natl Acad. Sci. USA93, 705–708 (1996).
   PubMed Web of Science ®Google Scholar
• Artlett AM, Smith B, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N. Engl. J. Med.338, 1186–1191 (1998).
   PubMed Web of Science ®Google Scholar
• Lambert NC, Evans PC, Hashizumi TL et al. Persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA*0501: implications in autoimmunity. J. Immunol.164, 5545–5548 (2000).
   PubMed Web of Science ®Google Scholar
• Nelson JL. Microchimerism and autoimmune disease. N. Engl. J. Med.338, 1224–1225 (1998).
   PubMed Web of Science ®Google Scholar
• Gleicher N. Modern obstetrical and infertility care may increase the prevalence of disease: an evolutionary concept. Fertil. Steril.79, 249–252 (2003).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Barad D. An evolutionary concept of polycystic ovarian disease: does evolution favour reproductive success over survival? Reprod. Biomed. Online5, 587–589 (2006).
   Google Scholar
• Meyer JM, Evans TI, Small RE et al. HLA-DRB1 genotype influences risk and severity of rheumatoid arthritis. J. Rheumatol.26, 1024–1034 (1999).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self- tolerance and negative control of immune responses. Annu. Rev. Immunol.22, 531–562 (2004).
   PubMed Web of Science ®Google Scholar
• Kita M, Goulis DG, Avramides A. Post partum thyroiditis in a Mediterranean population. J. Endocrinol. Invest.25, 513–519 (2002).
   PubMed Web of Science ®Google Scholar
• Elkayam U, Akhter MW, Singh H et al. Pregnancy associated cardiomyopathy. Clinical characteristics and a comparison between early and late presentation. Circulation111, 2050–2055 (2005).
   PubMed Web of Science ®Google Scholar
• Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JC. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin. Rev. Allergy Immunol.23, 301–324 (2002).
   PubMed Web of Science ®Google Scholar
• Argarwal RK, Chan C-C, Wiggert B, Caspi RR. Pregnancy ameliorates induction and expression of experimental autoimmune uveitis. J. Immunol.162, 2648–2654 (1999).
   PubMed Web of Science ®Google Scholar
• Gogas H, Ioannovich J, Dafni U et al. prognostic significance of autoimmunity during treatment of melanoma with interferon. N. Engl. J. Med.354, 708–719 (2006).
   Google Scholar
• Scott JS. Immunological diseases and pregnancy. Br. Med. J.1, 1559–1567 (1966).
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Segol G, Segol O et al. Detection of antibodies to histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum.30, 169–175 (1987).
   PubMedGoogle Scholar
• Hardy CJ, Palmer BP, Morton SJ, Muir KR, Powell RJ. Pregnancy outcome and family size in systemic lupus erythematosus: a case control study. Rheumatology38, 559–563 (1999).
   PubMed Web of Science ®Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med.349, 1526–1533 (2003).
   PubMed Web of Science ®Google Scholar
• Shmerling RH. Autoantibodies in systemic lupus erythematosus – there before you know it. N. Engl. J. Med.349, 1499 (2003).
   PubMed Web of Science ®Google Scholar
• Scofield RH. Autoantibodies as predictors of disease. Lancet363, 1544–1546 (2004).
   PubMed Web of Science ®Google Scholar
• Gleicher N. Reproductive failure prior to the onset of clinical autoimmune disease. Rheumatology38, 485–487 (1999).
   PubMed Web of Science ®Google Scholar
• Cowchock S, Smith JB, Gocial B. Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am. J. Obstet. Gynecol.155, 1002–1010 (1986).
   PubMed Web of Science ®Google Scholar
• Gleicher N, El-Roeiy A, Confino E, Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am. J. Obstet. Gynecol.160, 1376–1385 (1989).
   PubMed Web of Science ®Google Scholar
• Sher G, Matzner W, Chong P, Ching W. The generalizability of antiphospholipid testing? Fertil. Steril.74, 611–612 (2000).
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Aging and infertility in women: a Committeee Opinion. Fertil. Steril.78, 2159 (2002).
   Google Scholar
• Choudhury A, Mukherjee P, Basu SK, George A, Rath S, Bal V. Disruption of T cell tolerance to self-immunoglobulin causes polyclonal B cell stimulation followed by inactivation of responding autoreactive T cells. J. Immunol.164, 1713–1721 (2000).
   PubMed Web of Science ®Google Scholar
• Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic, and anti-Sjögren’s syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin. Immunol. Immunopathol.36, 120–128 (1985).
   PubMedGoogle Scholar
• Bach JF, Kouyouzov S. New clues to systemic lupus. Lancet350(Suppl. 3), 11 (1997).
   Google Scholar
• Suzuki N, Mihara S, Sakane T. Development of pathogenic anti-DNA antibodies in patients with systemic lupus erythematosus. FASEB J.11, 1033–1038 (1997).
   PubMed Web of Science ®Google Scholar
• Harger JH, Rabin BS, Marchese SG. The prognostic value of antinuclear antibodies in women with recurrent pregnancy losses: a prospective controlled study. Obstet. Gynecol.73, 419–424 (1998).
   Google Scholar
• Gleicher N, El Roeiy A, Confino E, Friberg J. Is endometriosis an autoimmune disease? Obstet. Gynecol.70, 115–122 (1987).
   PubMed Web of Science ®Google Scholar
• Taylor PV, Campbell JM, Scott JS. Presence of autoantibodies in women with unexplained infertility. Am. J. Obstet. Gynecol.161, 377–379 (1989).
   PubMed Web of Science ®Google Scholar
• Hill GA. It’s not what you don’t know that makes you look like a fool. It’s what you do know that ain’t so. Fertil. Steril.74, 637–638 (2000).
   PubMed Web of Science ®Google Scholar
• Kay A, Bash F. Subfertility before and after development of rheumatoid arthritis in women. Ann. Rheum. Dis.24, 169–173 (1965).
   PubMed Web of Science ®Google Scholar
• Nelson JL, Koepsell TD, Dugowson CE, Voigt LF, Daling JR, Hansen JA. Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum.36, 7–14 (1993).
   PubMed Web of Science ®Google Scholar
• Silman AJ, Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann. Rheum.47, 441–444 (1988).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Barad D. Unexplained infertility: does it really exist? Hum. Reprod.21, 1951–1955 (2006).
   PubMed Web of Science ®Google Scholar
• Scott RT Jr. Déja vu all over again. Fertil. Steril.74, 639–640 (2000).
   PubMed Web of Science ®Google Scholar
• Lubbe WF, Bulter WS, Palmer SJ. Lupus anticoagulant in pregnancy. Br. J. Obstet. Gynaecol.91, 357–363 (1984).
   PubMedGoogle Scholar
• Gleicher N, Friberg J. IgM gammopathy and lupus anticoagulant syndrome in habitual aborters. JAMA253, 3278–3281 (1985).
   PubMed Web of Science ®Google Scholar
• Lockwood CJ, Reece EA, Romero R, Hobbins JC. Antiphospholipid antibody and pregnancy wastage. Lancet2, 742–743 (1986).
   PubMedGoogle Scholar
• Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins J. The prevalence and biological significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am. J. Obstet. Gynecol.161, 369–373 (1989)
   PubMed Web of Science ®Google Scholar
• Balasch J, Font J, Lopez-Sota A et al. Antiphospholipid antibodies in unselected patients with repeated abortion. Hum. Reprod.5, 43–46 (1990).
   PubMed Web of Science ®Google Scholar
• Gleicher N. Autoantibodies and pregnancy loss. Lancet343, 747–748 (1994).
   PubMed Web of Science ®Google Scholar
• Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N. Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss. Am. J. Obstet. Gynecol.168, 837–841 (1993).
   PubMed Web of Science ®Google Scholar
• Petri M, Golbus M, Anderson R, Whiting-O’Keefe Q, Corash L, Hellmann D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. Arthritis Rheum.30, 601–606 (1987).
   PubMedGoogle Scholar
• Eroglu GE, Scopelites E. Antinuclear and antiphospholipid antibodies in healthy women with recurrent spontaneous abortion. Am. J. Reprod. Immunol.31, 1–6 (1994).
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Carp HJ, Molina V et al. Autoantibodies and prediction of reproductive failure. Am. J. Reprod. Immunol.56, 337–344 (2006).
   PubMed Web of Science ®Google Scholar
• Lockshin MD. Antiphospholipid antibody syndrome. Rheum. Dis. Clin. North Am.20, 45–59 (1994).
   PubMed Web of Science ®Google Scholar
• Khamashta MA, Cuadrado MJ, Mujic F et al. The management of thrombosis in the antiphospolipid antibody syndrome. N. Engl. J. Med.332, 993–997 (1995).
   PubMed Web of Science ®Google Scholar
• Triplet DA. Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause. Arch. Path. Lab. Med.117, 78–88 (1993).
   PubMed Web of Science ®Google Scholar
• Gleicher N, El Roeiy A. The reproductive autoimmune failure syndrome (RAFS). Am. J. Obstet. Gynecol.159, 223–227 (1988).
   PubMed Web of Science ®Google Scholar
• Weed JC, Arguembourg PC. Endometriosis: can it produce an autoimmune response resulting in infertility? Clin. Obstet. Gynecol.23, 885–893 (1980).
   PubMedGoogle Scholar
• Fish B, Rikover Y, Shohat L et al. The relationship between in vitro fertilization and naturally occurring antibodies: evidence for increased production of antiphospholipid antibodies. Fertil. Steril.56, 718–724 (1991).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Liu HC, Dudkiewicz A et al. Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success. Am. J. Obstet. Gynecol.170, 1145–1149 (1994).
   PubMed Web of Science ®Google Scholar
• Geva E, Yaron Y, Lessing JB et al. Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertil. Steril.62, 802–806 (1994).
   PubMed Web of Science ®Google Scholar
• Geva E, Amit A, Lerner-Geva L, Azem F, Yovel Y, Lessing JB. Autoimmune disorders: another possible cause for in vitro fertilization and embryo transfer failure. Hum. Reprod.10, 101–104 (1995).
   Google Scholar
• Gleicher N, Vidali A, Karande V. The immunological “Wars of the Roses”: disagreements amongst reproductive immunologists. Hum. Reprod.17, 539–542 (2002).
   PubMed Web of Science ®Google Scholar
• Hornstein MD, Davis OK, Massey JB et al. Antiphospholipid antibodies and in vitro fertilization success: a meta analysis. Fertil. Steril.73, 330–333 (2000).
   PubMed Web of Science ®Google Scholar
• Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome in naïve mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc. Natl Acad. Sci. USA88, 3069–3073 (1991).
   PubMed Web of Science ®Google Scholar
• Geva E, Amit A, Lerner-Geva L, Lessing JB. Autoimmunity and reproduction. Fertil. Steril.67, 599–611 (1997).
   PubMed Web of Science ®Google Scholar
• Aoki K, Dudkiewicz AB, Matsuura E, Novotny M, Kaberlein G, Gleicher N. Clinical significance of β2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems. Am. J. Obstet. Gynecol.172, 926–931 (1995).
   PubMed Web of Science ®Google Scholar
• Coulam C, Kaider B, Janovicz P, Roussev R. Antiphospholipid antibodies associated with implantation failure after IVF/ET. J. Assist. Reprod. Genet.14, 603–608 (1997).
   PubMed Web of Science ®Google Scholar
• Peaceman AM, Silver RK, MacGregor SN, Socol ML. Interlaboratory variation in antiphospholipid antibody testing. Am. J. Obstet. Gynecol.166, 1780–1787 (1992).
   PubMed Web of Science ®Google Scholar
• Harris EN. Special report: the second international anti-cardiolipin standardization workshop/the Kingston Antiphospholipid Antibody Study (KAPS) group. Am. J. Clin. Pathol.94, 476–484 (1990).
   PubMed Web of Science ®Google Scholar
• Coulam CB, McIntyre JR, Wagenknecht D, Rote N. Inter-laboratory inconsistencies in detection of anticardiolipin antibodies. Lancet335, 865 (1990).
   PubMed Web of Science ®Google Scholar
• Harries EN, Gharavi E, Patel SP, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held April 4, 1986. Clin. Exp. Immunol.68, 215–222 (1987).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Harlow L, Zilberstein M. Regulatory effect of antiphospholipid antibodies on signal transduction. Am. J. Obstet. Gynecol.167, 637–642 (1992).
   PubMed Web of Science ®Google Scholar
• Ware-Branch D, Rodgers GM. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism for thrombosis. Am. J. Obstet. Gynecol.168, 206–210 (1993).
   PubMed Web of Science ®Google Scholar
• Peaceman AM, Rehnberg KA. The immunoglobulin G fraction from plasma containing antiphospholipid antibodies causes increased placental thromboxane production. Am. J. Obstet. Gynecol.167, 1543–1547 (1992).
   PubMed Web of Science ®Google Scholar
• Adler RR, Ng A-K, Rote NS. Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line. JAR Biol. Reprod.53, 905–910 (1995).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Caplan L, Michaud K. Treatment of rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum.54, 628–634 (2006).
   PubMed Web of Science ®Google Scholar
• Brannagan TH 3rd. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies. Neurology59(Suppl. 6), S33–S40 (2002).
   PubMed Web of Science ®Google Scholar
• Sher G, Matzner W, Feinman M et al. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody positive women undergoing in vitro fertilization. Am. J. Reprod. Immunol.40, 74–82 (1998).
   PubMed Web of Science ®Google Scholar
• Sher G, Zouves C, Feinman M et al. A rational basis for the use of heparin/aspirin and IV-IG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. Am. J. Reprod. Immunol.39, 391–394 (1998).
   PubMed Web of Science ®Google Scholar
• Many A, Pauzner R, Carp H, Langevitz P, Martinowitz U. Treatment of patients with antiphospholipid antibodies during pregnancy. Am. J. Reprod. Immunol.28, 216–218 (1992).
   PubMed Web of Science ®Google Scholar
• Hasegawa I, Takakuwa K, Goto S et al. Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody. Hum. Reprod.7, 203–207 (1992).
   PubMed Web of Science ®Google Scholar
• De Carolis C, Greco E, Guarino MD et al. Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters. Am. J. Reprod. Immunol.52, 263–266 (2004).
   PubMed Web of Science ®Google Scholar